Of the five companies that currently sell adderall, Mylan is completely out of stock, Nesher can’t get the active ingredient and Aurobindo has the drug under allocation. Only Teva and Sandoz show they have Adderall available.
“The situation shows how sensitive the U.S. generic system has become. There is limited spare capacity and even commodity products can come out of stock,” analyst Ronny Gal, PhD, wrote to investors, according to STAT.
More articles on pharmacy:
Novant Health leaders talk Walgreens partnership goals for 2020
Sanofi recalls heartburn drug over cancer risks
Cheating scandal prompts California to invalidate pharmacist test scores
